Arq Bras Cardiol: Imagem cardiovasc 2023; 36(1): e358
Radiotherapy-Induced Heart Disease: What Can We Evaluate?
Radiotherapy (RT) has been part of oncological treatment since 1899 and is currently used with more than 50% of all patients. Breast, lung, esophagus, and lymphoma tumors are commonly submitted to RT treatment, showing improvements in the total survival and freedom from diseases. By contrast, when including mediastinal structures, such as the heart and blood vessels, in 10% to 30% of the patients, adverse cardiovascular events were observed after 5 and 10 years, defined as Radiation-Induced Heart Disease (RIHD).,
The RIHD spectrum includes pericardial diseases, coronary artery disease, valvar heart disease, cardiomyopathy, as well as conduction abnormality and dysautonomia, leading to an increase in the cardiovascular morbidity and mortality of the survivors.
[…]
Keywords: Cardiotoxicity; Echocardiography; Radiotherapy
274
